Shingles is not caused by COVID-19 vaccines. Here’s the science
Physicians in Israel recently reported that six women with autoimmune disorders developed the painful rash known as shingles 3 to 14 days after they received a...
Daily Archive: April 22, 2021
‘Breakthrough’ COVID infections after vaccination very rare: study
(HealthDay)—COVID-19 “breakthrough” infections, where someone who’s been fully vaccinated becomes infected nonetheless, are exceedingly rare, a new study suggests.
How to make sure everyone gets a fair shot at the COVID-19 vaccine
Getting vaccinated may be everyone’s best protection against COVID-19. But giving everyone fair access to vaccines will take more than just providing needles and vials, community...
India’s COVID-19 surge and the new variant: what we know
India is battling a record-breaking rise in COVID-19 infections that has overwhelmed hospitals and led to severe bed and oxygen shortages.
Recovered but RT-PCR-positive individuals unlikely to transmit SARS-CoV-2
(HealthDay)—Individuals who have clinically recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and continue to test positive for viral RNA after completing the recommended...
Fortnite challenge: Stay within 20m of a player for 3 secs, wearing a disguise
In this guide, we’ll show you how to stay within 20m of a player for 3 seconds while wearing a prop disguise as part of Fortnite’s...
MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model
A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in...
Researchers identify predictive factors of delirium in Sub-Saharan Africa
Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published...
COVID-19 vaccine development built on $17 billion in NIH funding for vaccine technologies
The unprecedented development of COVID-19 vaccines less than a year after discovery of this virus was enabled by more than $17 billion of research on vaccine...
Among COVID-19 survivors, an increased risk of death, serious illness
As the COVID-19 pandemic has progressed, it has become clear that many survivors—even those who had mild cases—continue to manage a variety of health problems long...
